Skip to main navigation
  • About
    • Overview
    • Mission & Vision
    • Management
    • Board of Directors
  • Science
    • Overview
    • Therapeutic Areas
    • Therapeutic Platforms
    • Technology Platforms
    • Publications
  • Our Medicine
    • PAPZIMEOS
  • Pipeline
    • Overview
    • Precigen Pipeline
    • Expanded Access Policy
  • Careers
    • Overview
    • Job Postings
    • Postdoc Program
    • Benefits
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
    • Financials
    • Governance
    • Resources
  • Contact
    • Contact
    • Location
  • About
    • Overview
    • Mission & Vision
    • Management
    • Board of Directors
  • Science
    • Overview
    • Therapeutic Areas
    • Therapeutic Platforms
    • Technology Platforms
    • Publications
  • Our Medicine
    • PAPZIMEOS
  • Pipeline
    • Overview
    • Precigen Pipeline
    • Expanded Access Policy
  • Careers
    • Overview
    • Job Postings
    • Postdoc Program
    • Benefits
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
    • Financials
    • Governance
    • Resources
  • Contact
    • Contact
    • Location
PRECIGEN Investors

Press Releases

IR Nav

  • Press Releases
  • Events & Presentations
  • Stock
  • Financials
  • Governance
  • Resources

Press Releases

Mar 30, 2026
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
Learn More
Mar 25, 2026
Precigen Reports Full Year 2025 Financial Results and Business Updates
Learn More
Mar 11, 2026
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25
Learn More
Jan 20, 2026
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
Learn More
Jan 12, 2026
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
Learn More
Jan 05, 2026
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
Learn More

Upcoming Events

More events are coming soon.

Media Kit

Precigen maintains a media kit that can be used by media for editorial purposes. Should you have any questions or seek assets not included in our media kit, please contact:

press@precigen.com

Access
Media Kit
View Kit
Advancing Medicine with precision®
  • About
    • Overview
    • Mission & Vision
    • Management
    • Board of Directors
  • Science
    • Overview
    • Therapeutic Areas
    • Therapeutic Platforms
    • Technology Platforms
    • Publications
  • Our Medicine
    • PAPZIMEOS
  • Pipeline
    • Overview
    • Precigen Pipeline
    • Expanded Access Policy
  • Careers
    • Overview
    • Job Postings
    • Postdoc Program
    • Benefits
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
    • Financials
    • Governance
    • Resources
  • Contact
    • Contact
    • Location

Headquarters

Precigen, Inc.
20358 Seneca Meadows Parkway
Germantown, MD 20876

Connect

  • linkedin
  • twitter
  • youtube

Privacy and Legal Menu

  • Privacy Policy
  • Legal Notices
  • Do Not Sell/Share My Personal Information

Copyright

© Precigen. All Rights Reserved.